Biomarkers of disease activity in patients with chronic spontaneous urticaria

被引:13
|
作者
Plavsic, Aleksandra [1 ,2 ]
Tomic-Spiric, Vesna [1 ,2 ]
Arandjelovic, Snezana [1 ,2 ]
Miskovic, Rada [1 ,2 ]
Dimitrijevic, Milan [2 ]
Peric-Popadic, Aleksandra [1 ,2 ]
机构
[1] Univ Belgrade, Fac Med, Dept Internal Med, Koste Todorov 2, Belgrade 11000, Serbia
[2] Univ Clin Ctr Serbia, Clin Allergy & Clin Immunol, Belgrade, Serbia
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2021年 / 38卷 / 06期
关键词
chronic spontaneous urticaria; biomarkers; disease activity; C-REACTIVE PROTEIN; PLASMA-LEVELS; BLOOD-COAGULATION; SEVERITY; MATRIX-METALLOPROTEINASE-9; ACTIVATION; PATHWAY;
D O I
10.5114/ada.2021.112276
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Previous studies have examined biomarkers of coagulation, inflammation and immunity in chronic spontaneous urticaria (CSU), but no recommended biomarkers for disease activity have been established yet. Aim: To find the relationship between certain laboratory parameters and disease activity in patients with CSU. Material and methods: Serum concentrations of D-dimer, C-reactive protein (CRP), C3, C4, and prothrombin time (PT), activated partial thromboplastin time (aPTT) values were measured in 44 CSU patients and compared with 33 healthy controls. Correlation between biomarkers and urticaria activity score during 7 consecutive days (UAS7) was calculated. Results: Our study included 44 CSU patients (38 females and 6 males), mean age of 50.4 years and the average disease duration of 3.1 years. Based on UAS7, 23 (52.3%) CSU patients had mild urticaria, 8 (18.2%) well-controlled, 7 (15.9%) moderate and 6 (13.6%) severe urticaria. Fourteen (31.8%) patients had elevated CRP, 21 (47.7%) had el- evated D-dimer and 14 (13.6%) CSU patients had elevated C4 levels. Patients with CSU had statistically significant elevated D-dimer, CRP and PT as compared with controls (p = 0.007, p = 0.005 and p = 0.029, respectively). There was no correlation between PT, aPTT, D-dimer, CRP, C3 and disease activity. Statistically significant differences in C4 levels between patients with severe and well-controlled, mild, moderate urticaria were determined (p = 0.003). Conclusions: CRP, D-dimer, and PT may be considered as biomarkers for distinguishing patients with CSU from controls. The C4 levels correlate with disease activity and may be useful as a potential biomarker of disease activity.
引用
收藏
页码:1017 / 1022
页数:6
相关论文
共 50 条
  • [31] Association of serum biochemical indexes and thyroid nodule with disease activity in patients with chronic spontaneous urticaria
    Su, Yuan-Ting
    Cui, Wei
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [32] Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria
    Carvallo, Alvaro
    Veleiro, Beatriz
    Sabate-Bresco, Marina
    Baeza, Maria Luisa
    Guilarte, Mar
    Herrera-Lasso, Valeria
    Rodriguez-Garijo, Nuria
    Donado, Carmen Diaz
    Labrador-Horrillo, Moises
    Ferrer, Marta
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (01): : 195 - 200
  • [33] Histamine release test correlates with disease activity in chronic spontaneous urticaria
    Berti, A.
    Yacoub, M. R.
    Skov, P. S.
    Casati, L.
    Colombo, G. M.
    ALLERGY, 2015, 70 : 153 - 154
  • [34] PSYCHOMETRIC EVALUATION OF THE URTICARIA ACTIVITY SCORE IN CHRONIC SPONTANEOUS URTICARIA
    Whalley, D.
    Balp, M. M.
    Yarr, S.
    Korver, D.
    Toran, S. Sauchelli
    Kohli, R.
    Orfanos, P.
    VALUE IN HEALTH, 2024, 27 (12)
  • [35] Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria
    Chanprapaph, Kumutnart
    Iamsumang, Wimolsiri
    Wattanakrai, Penpun
    Vachiramon, Vasanop
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [36] The Role Of Serum Biomarkers In Predicting Response To Omalizumab Therapy In Patients With Chronic Spontaneous Urticaria
    Cain, Wesley
    Ghosh, Debajyoti
    Bernstein, Jonathan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB77 - AB77
  • [37] Chronic spontaneous urticaria and thyroid autoimmune disease: A follow up study of patients with chronic urticaria for 17 years
    Mouco, C. C.
    Zanadrea, A.
    Kalil, J.
    Motta, A. A.
    Agondi, R. C.
    Brugnolli, R. M.
    ALLERGY, 2018, 73 : 554 - 554
  • [38] Identification of biomarkers for treatment duration and controller dose of omalizumab in patients with chronic spontaneous urticaria
    Fernandez, L. Zubiaga
    Testera-Montes, A.
    Sanchez, N. Perez
    Perez, F. Gomez
    Dona, I.
    Maria, R. Saenz De Santa
    Bartra, J.
    Eguiluz, I.
    Ferrer, M.
    Torres, MJ.
    ALLERGY, 2023, 78 : 89 - 89
  • [39] Disease Control and Treatment Satisfaction in Patients with Chronic Spontaneous Urticaria in Japan
    Fukunaga, Atsushi
    Kishi, Yuko
    Arima, Kazuhiko
    Fujita, Hiroyuki
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [40] Omalizumab Updosing for Better Disease Control in Chronic Spontaneous Urticaria Patients
    Kocaturk, Emek
    Deza, Gustavo
    Kiziltac, Kubra
    Gimenez-Arnau, Ana M.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2018, 177 (04) : 360 - 364